The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
903
August 20, 1993
View Complete Issue         Table of Contents 2019 
Enoxaparin - A Low-Molecular-Weight Heparin
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Enoxaparin - A Low-Molecular-Weight Heparin
August 20, 1993 (Issue: 903)
Enoxaparin (Lovenox - Rh ne-Poulenc Rorer), the first low-molecular-weight heparin to become commercially available in the USA, was recently approved by the US Food and Drug Administration for prevention of deep vein thrombosis following hip...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Enoxaparin - A Low-Molecular-Weight Heparin
Article code: 903a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.